Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
PubMed
Google Scholar
Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.
Article
CAS
PubMed
Google Scholar
Kaur RP, Vasudeva K, Kumar R, Munshi A. Role of p53 gene in breast Cancer: focus on mutation Spectrum and therapeutic strategies. Curr Pharm Des. 2018;24:3566–75.
Article
CAS
PubMed
Google Scholar
Gallardo-Alvarado LN, Tusié-Luna MT, Tussié-Luna MI, et al. Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population. BMC Cancer. 2019;19:118.
Article
PubMed
PubMed Central
Google Scholar
Diakite B, Kassogue Y, Dolo G, Kassogue O, Keita ML, Joyce B, et al. Association of PIN3 16-bp duplication polymorphism of TP53 with breast cancer risk in Mali and a meta-analysis. BMC Med Genet. 2020;21:142.
Article
CAS
PubMed
PubMed Central
Google Scholar
Aubrey BJ, Strasser A. Kelly GLTumor-suppressor functions of the TP53 pathway. Cold Spring HarbPerspect Med. 2016;6:a026062.
Article
CAS
Google Scholar
Damineni S, Rao VR, Kumar S, et al. Germline mutations of TP53 gene in breast cancer. Tumour Biol. 2014;35:9219–27.
Article
CAS
PubMed
Google Scholar
Mhawech P, Kinkel K, Vlastos G, Pelte M-F. Ovarian carcinomas in endometriosis: an immunohistochemical and comparative genomic hybridization study. Int J GynecolPathol. 2002;21:401–6.
Article
Google Scholar
Sagne C, Marcel V, Amadou A, Hainaut P, Olivier M, Hall J. A meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effects. Cell Death Dis. 2013;4:e492.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kung CP, Leu JI, Basu S, et al. The P72R polymorphism of p53 predisposes to obesity and metabolic dysfunction. Cell Rep. 2016;14:2413–25.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou Y, Li N, Zhuang W, Liu G-J, Wu T-X, Yao X, et al. P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature. Int J Cancer. 2007;121:1481–6.
Article
CAS
PubMed
Google Scholar
Menzel H-J, Sarmanova J, Soucek P, Berberich R, Grünewald K, Haun M, et al. Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations. Br J Cancer. 2004;90:1989–94.
Article
CAS
PubMed
PubMed Central
Google Scholar
Akkiprik M, Sonmez O, Gulluoglu BM, Caglar HB, Kaya H, Demirkalem P, et al. Analysis of p53 gene polymorphisms and protein over-expression in patients with breast cancer. Pathol Oncol Res. 2009;15:359–68.
Article
CAS
PubMed
Google Scholar
Krivokuca AM, Malisic EJ, Dobricic JD, Brotto KV, Cavic MR, Jankovic RN, et al. RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women. Familial Cancer. 2014;13(2):173–80.
Article
CAS
PubMed
Google Scholar
Dahabreh IJ, Schmid CH, Lau J, Varvarigou V, Murray S, Trikalinos TA. Genotype misclassification in genetic association studies of the rs1042522 TP53 (Arg72Pro) polymorphism: a systematic review of studies of breast, lung, colorectal, ovarian, and endometrial cancer. Am J Epidemiol. 2013;177:1317–25.
Article
PubMed
PubMed Central
Google Scholar
Bisof V, Salihović MP, Narancić NS, Skarić-Jurić T, Jakić-Razumović J, Janićijević B, et al. TP53 gene polymorphisms and breast cancer in Croatian women: a pilot study. Eur J Gynaecol Oncol. 2010;31:539–44.
CAS
PubMed
Google Scholar
Habyarimana T, Attaleb M, Mugenzi P, Mazarati JB, Bakri Y, El Mzibri M. Association of p53 codon 72 polymorphism with breast Cancer in a Rwandese population. Pathobiology. 2018;85:186–91.
Article
CAS
PubMed
Google Scholar
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
Article
CAS
PubMed
Google Scholar
Higgins JPT. In: Green S, editor. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]: The Cochrane Collaboration; 2011. Available from http://handbook.cochrane.org.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Alshatwi AA, Hasan TN, Shafi G, Alsaif MA, Al-Hazzani AA, Alsaif AA. A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population. Fundam Clin Pharmacol. 2012;26:438–43.
Article
CAS
PubMed
Google Scholar
Ayoubi SE, Elkarroumi M, El Khachibi M, HassaniIdrissi H, Ayoubi H, Ennachit S, et al. The 72Pro variant of the tumor protein 53 is associated with an increased breast Cancer risk in the Moroccan population. Pathobiology. 2018;85:247–53.
Article
CAS
PubMed
Google Scholar
Buyru N, Tigli H, Dalay N. P53 codon 72 polymorphism in breast cancer. Oncol Rep. 2003;10:711–4.
CAS
PubMed
Google Scholar
Cherdyntseva NV, Denisov EV, Litviakov NV, Maksimov VN, Malinovskaya EA, Babyshkina NN, et al. Crosstalk between the FGFR2 and TP53 genes in breast cancer: data from an association study and epistatic interaction analysis. DNA Cell Biol. 2012;31:306–16.
Article
CAS
PubMed
Google Scholar
Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R, et al. Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer. BMC Cancer. 2008;8:32.
Article
PubMed
PubMed Central
CAS
Google Scholar
Cox DG, Deer D, Guo Q, Tworoger SS, Hankinson SE, Hunter DJ, et al. The p53 Arg72Pro and MDM2–309 polymorphisms and risk of breast cancer in the nurses’ health studies. Cancer Causes Control. 2007;18:621–5.
Article
PubMed
Google Scholar
Denisov EV, Cherdyntseva NV, Litvyakov NV, Slonimskaya EM, Malinovskaya EA, Voevoda MI, et al. TP53 mutations and Arg72Pro polymorphism in breast cancers. Cancer Genet Cytogenet. 2009;192:93–5.
Article
CAS
PubMed
Google Scholar
Ebner F, Schremmer-Danninger E, Rehbock J. The role of TP53 and p21 gene polymorphisms in breast cancer biology in a well specified and characterized German cohort. J Cancer Res Clin Oncol. 2010;136:1369–75.
Article
CAS
PubMed
Google Scholar
Hossain A, Murshid GMM, MNH Z, Islam F, Sultana R, Sultana T, et al. TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population. Breast Cancer. 2017;24:571–8.
Article
PubMed
Google Scholar
Isakova J, Talaibekova E, Aldasheva N, Vinnikov D, Aldashev A. The associationof polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309Gof MDM2 gene with breast cancer in Kyrgyz females. BMC Cancer. 2017;17(1):758.
Article
PubMed
PubMed Central
CAS
Google Scholar
Katiyar S, Thelma BK, Murthy NS, Hedau S, Jain N, Gopalkrishna V, et al. Polymorphism of the p53 codon 72 Arg/pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Mol Cell Biochem. 2003;252:117–24.
Article
CAS
PubMed
Google Scholar
Li T, Lu ZM, Guo M, Wu QJ, Chen KN, Xing HP, et al. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Cancer. 2002;15(95):2571–6.
Article
CAS
Google Scholar
Ma H, Hu Z, Zhai X, Wang S, Wang X, Qin J, et al. Joint effects of single nucleotide polymorphisms in P53BP1 and p53 on breast cancer risk in a Chinese population. Carcinogenesis. 2006;27:766–71.
Article
CAS
PubMed
Google Scholar
Sharma S, Sambyal V, Guleria K, Manjari M, Sudan M, Uppal MS, et al. TP53 polymorphisms in sporadic north Indian breast cancer patients. Asian Pac J Cancer Prev. 2014;15:6871–9.
Article
PubMed
Google Scholar
Song F, Zheng H, Liu B, Wei S, Dai H, Zhang L, et al. An miR-502-binding site single-nucleotide polymorphism in the 3′-untranslated region of the SET8 gene is associated with early age of breast cancer onset. Clin Cancer Res. 2009;15:6292–300.
Article
CAS
PubMed
Google Scholar
Sprague BL, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L, Hampton JM, et al. Genetic variation in TP53 and risk of breast cancer in a population-based case control study. Carcinogenesis. 2007;28:1680–6.
Article
CAS
PubMed
Google Scholar
Wang-Gohrke S, Becher H, Kreienberg R, Runnebaum IB, Chang-Claude J. Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years. Pharmacogenetics. 2002;12:269–72.
Article
CAS
PubMed
Google Scholar
Zhang W, Jin MJ, Chen K. Association of p53 polymor-phisms and its haplotypes with susceptibility of breast cancer. Zhejiang Da XueXue Bao Yi Xue Ban. 2007;36:561–6.
CAS
Google Scholar
Arfaoui A, Douik H, Kablouti G, Chaaben AB, Handiri N, Zid Z, et al. Role of p53 Codon72 SNP in breast Cancer risk and Anthracycline resistance. AnticancerRes. 2015;35:1763–9.
Google Scholar
Faghani M, Nikbahkt M, Salehi M, Rabbani M, Talebi A, Soleima-ni B, et al. Study of p53 polymorphism at codon 72 in patients of breast cancer in Isfahan. J Isfahan Med School. 2007;25:26–33.
Google Scholar
Chabnaz S, Ahmed MU, Islam MS, Islam MR, Al-Mamun MM, Islam MS, et al. Breast cancer risk in relation to TP53 codon 72 and CDH1 gene polymorphisms inthe Bangladeshi women. Tumour Biol. 2016;37:7229–37.
Article
CAS
Google Scholar
Yadav P, Masroor M, Tanwer K, Mir R, Javid J, Ahmad I, et al. Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients. Clin Transl Oncol. 2016;18:728–34.
Article
CAS
PubMed
Google Scholar
Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G. Breast cancer. Lancet. 2005;365:1727–41.
Article
PubMed
Google Scholar
Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med. 2006;354:270–82.
Article
CAS
PubMed
Google Scholar
Stracquadanio G, Wang X, Wallace MD, Grawenda AM, Zhang P, Hewitt J, et al. The importance of p53 pathway genetics in inherited and somatic cancer genomes. Nat Rev Cancer. 2016;16:251–65.
Article
CAS
PubMed
PubMed Central
Google Scholar
Candeias MM, Malbert-Colas L, Powell DJ, Daskalogianni C, Maslon MM, Naski N, et al. P53 mRNA controls p53 activity by managing Mdm2 functions. Nat Cell Biol. 2008;10:1098–105.
Article
CAS
PubMed
Google Scholar
Dumont P, Leu JI, Della Pietra AC 3rd, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. NatGenet. 2003;33:357–65.
CAS
Google Scholar
Rohaly G, Chemnitz J, Dehde S, Nunez AM, Heukeshoven J, Deppert W, et al. A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint. Cell. 2005;122:21–32.
Article
CAS
PubMed
Google Scholar
Basu S, Gnanapradeepan K, Barnoud T, Kung CP, Tavecchio M, et al. Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α. Genes Dev. 2018;32:230–43.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jafrin S, Aziz MA, Anonna SN, Akter T, Naznin NE, Reza S, et al. Association of TP53 codon 72 Arg>pro polymorphism with breast and lung Cancer risk in the south Asian population: a meta-analysis. Asian Pac J Cancer Prev. 2020;21:1511–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Akhter N, Dar SA, Chattopadhyay S, Haque S, Anwer R, Wahid M, et al. Impact of p53 arg72pro SNP on breast Cancer risk in north Indian population. Curr Genomics. 2018;19(5):395–410..
Article
CAS
PubMed
PubMed Central
Google Scholar
Khan MH, Khalil A, Rashid H. Evaluation of the p53 Arg72Pro polymorphism and its association with cancer risk: aHuGE review and meta-analysis. Genet Res (Camb). 2015;97:e7.
Article
CAS
Google Scholar
Hou J, Jiang Y, Tang W, Jia S. p53 codon 72 polymorphism and breast cancer risk: A meta-analysis. Exp Ther Med. 2013;5:1397–402 2013.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhuo W, Zhang Y, Xiang Z, Cai L, Chen Z. Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controls. J Exp Clin Cancer Res. 2009;28:115.
Article
PubMed
PubMed Central
CAS
Google Scholar
Francisco G, Menezes PR, Eluf-Neto J, Chammas R. Arg72Pro TP53 polymorphism and cancer susceptibility: a comprehensive meta-analysis of 302 case-control studies. Int J Cancer. 2011;129:920–30.
Article
CAS
PubMed
Google Scholar
Ma Y, Yang J, Liu Z, Zhang P, Yang Z, Wang Y, et al. No significant association between the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis of 21 studies involving 24,063 subjects. Breast Cancer Res Treat. 2011;125:201–5.
Article
PubMed
Google Scholar
Gonçalves ML, Borja SM, Cordeiro JABL, Saddi VA, Ayres FM, Vilanova-Costa CAST, et al. Association of the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis. Springerplus. 2014;3:749.
Article
PubMed
PubMed Central
CAS
Google Scholar
Thomas D. Gene–environment-wide association studies: emerging approaches. Nat Rev Genet. 2010;11:259–72.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wood AR, Hernandez DG, Nalls MA, Yaghootkar H, Gibbs JR, Harries LW, et al. Allelic heterogeneity and more detailed analyses of known loci explain additional phenotypic variation and reveal complex patterns of association. Hum Mol Genet. 2011;20:4082–92.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rosenberg NA, Huang L, Jewett EM, Szpiech ZA, Jankovic I, Boehnke M. Genome-wide association studies in diverse populations. Nat Rev Genet. 2010;11:356–66..
Article
CAS
PubMed
PubMed Central
Google Scholar
Murphy ME, Liu S, Yao S, Huo D, Liu Q, Dolfi SC. At al. A functionally significant SNP in TP53 and breastcancer risk in African-American women. NPJ. Breast Cancer. 2017;3:5.
PubMed
PubMed Central
Google Scholar
Ohayon T, Gershoni-Baruch R, Papa MZ, Distelman Menachem T, Eisenberg Barzilai S, Friedman E. The R72P P53 mutation is associated with familial breast cancer in Jewish women. Br J Cancer. 2005;92:1144–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Henríquez-Hernández LA, Murias-Rosales A, Hernández González A, Cabrera De León A, Díaz-Chico BN, Mori De Santiago M, et al. Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: a case-control study. Oncol Rep. 2009;22:1425–33.
Article
PubMed
CAS
Google Scholar
Papadakis EN, Dokianakis DN, Spandidos DA. p53 codon 72 polymorphism as a risk factor in the development of breast cancer. Mol Cell Biol Res Commun. 2000;3:389–92.
Article
CAS
PubMed
Google Scholar
Noma C, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women. Cancer Lett. 2004;210:197–203.
Article
CAS
PubMed
Google Scholar
Damin APS, Frazzon APG, Damin DC, Roehe A, Hermes V, Zettler C, et al. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk. Cancer Detect Prev. 2006;30:523arf–9.
Article
CAS
Google Scholar
Mahasneh AA, Abdel-Hafiz SS. Polymorphism of p53 gene in Jordanian population and possible associations with breast cancer and lung adenocarcinoma. Saudi Med J. 2004;25:1568–73.
PubMed
Google Scholar
Nordgard SH, Alnaes GIG, Hihn B, Lingjaerde OC, Liestøl K, Tsalenko A, et al. Pathway based analysis of SNPs with relevance to 5-FU therapy: relation to intratumoral mRNA expression and survival. Int J Cancer. 2008;123:577–85.
Article
CAS
PubMed
Google Scholar
Rajkumar T, Samson M, Rama R, Sridevi V, Mahji U, Swaminathan R, et al. TGFbeta1 (Leu10Pro), p53 (Arg72Pro) can predict for increased risk for breast cancer in south Indian women and TGFbeta1 pro (Leu10Pro) allele predicts response to neo-adjuvant chemo-radiotherapy. Breast Cancer Res Treat. 2008;112(1):81–7.
Article
CAS
PubMed
Google Scholar
Singh V, Rastogi N, Mathur N, Singh K, Singh MP. Association of polymorphism in MDM-2 and p53 genes with breast cancer risk in Indian women. Ann Epidemiol. 2008;18:48–57.
Article
PubMed
Google Scholar
Alawadi S, Ghabreau L, Alsaleh M, Abdulaziz Z, Rafeek M, Akil N, et al. P53 gene polymorphisms and breast cancer risk in Arab women. Med Oncol 2011;28:709–15..
Aoki MN, da Silva do Amaral Herrera AC, Amarante MK, do Val Carneiro JL, MHP F, MAE W. CCR5 and p53 codon 72 gene polymorphisms: implications in breast cancer development. Int J Mol Med. 2009;23:429–35.
CAS
PubMed
Google Scholar
Hrstka R, Beranek M, Klocova K, Nenutil R, Vojtesek B. Intronic polymorphisms in TP53 indicate lymph node metastasis in breast cancer. Oncol Rep. 2009;22:1205–11.
CAS
PubMed
Google Scholar
Kazemi M, Salehi Z, Chakosari RJ. TP53 codon 72 polymorphism and breast cancer in northern Iran. Oncol Res. 2009;18:25–30.
Article
CAS
PubMed
Google Scholar
Suresh K, Venkatesan R, Chandirasekar R, Kumar BL, Sasikala K. Association of Trp53 arg72pro polymorphic variants with breast cancer – a case control study in south Indian population. Biol Med. 2011;3:15–22.
CAS
Google Scholar